ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

TuberculosisSubscribe to Tuberculosis

At the Brunt of Tuberculosis

Why is India firefighting tuberculosis without adequate data surveillance?

Resource Optimisation for Tuberculosis Elimination in India

The World Health Organization's "End TB Strategy," envisages a tuberculosis free world, with a target to end the TB epidemic by 2035. For this, its member states, including India, have to secure sufficient resources. Despite India's high economic growth in an otherwise gloomy global economy, it struggles with a resource crunch to support its national strategic plan for effective TB control.

The Essential Cancer Drugs

There are no public procurement programmes for cancer on the lines of those that exist for AIDS or tuberculosis. It is worth considering whether it is feasible to institute a drug procurement programme based on international/national competitive bidding or shopping, like those already in place in the National AIDS Control Organisation. If patients in developed countries are finding it difficult to survive the astronomical prices of cancer drugs, a developing country like India, with a large part of its population below the poverty line or among the middle class, is even worse affected in the battle against the disease.

Health, Illness and Disease

The conceptions of disease and its formulation under different paradigms have made it clear that the approach towards health and medicine has never been completely detached from ecology. Health and disease are thought to be the products of the interaction among three key elements: the agent, the host, and the environment. This paper is an attempt to develop an approach that encompasses the concerns surrounding an understanding of disease ecology and a patient's behaviour during treatment. Using the example of tuberculosis patients put under DOTS, which disregards the patient's say in decision-making, it analyses the implications for the larger health issue using the political ecology approach.

The Ever-Mutating Enemy

Tuberculosis is spreading with renewed vigour globally as are its more virulent strains like multi-drug-resistant TB and extensively drug-resistant TB. Even as the bacteria mutates and there is urgent need to deal with the many inadequacies of the present treatment regimen, new drugs backed by innovative research are conspicuously absent. A new candidate anti-TB drug proposed to be tried by the Open Source Drug Discovery initiative with the Council of Scientifi c and Industrial Research offers a ray of hope.

India Needs a National Policy to Control Tuberculosis

There is no policy in India for tuberculosis control and the centrally-run Revised National Tuberculosis Control Programme has neither mandate nor agenda for TB control. There are short, medium and long term remedies for the maladies of the revised programme which are detailed in this article. TB is both a biomedical and a social, cultural and economic problem. Citizens must demand a national policy for TB control.
Back to Top